Erratum: FABP4 Induces Vascular smooth muscle cell proliferation and migration through a MAPK-Dependent Pathway (PLoS ONE (2013) 8:11 (e81914) (DOI:10.1371/journal.pone.0081914));FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Girona, Josefa ^a   Rosales, Roser ^a   Plana, Núria ^a   Saavedra, Paula ^a   Masana, Lluís ^a   Vallvé, Joan Carles ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN D1; FATTY ACID BINDING PROTEIN 4; FIBULIN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYC PROTEIN; PROTEIN C JUN; PROTEIN KINASE B;

ARTICLE; ASSAY; BROXURIDINE ASSAY; CCL2 GENE; CELL CYCLE REGULATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYCLIN D1 GENE; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYMOLOGY; FIBULIN 4 GENE; FIBULIN 5 GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CORONARY ARTERY SMOOTH MUSCLE CELL; MMP2 GENE; PROTEIN SPECIFICITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; FATTY ACID-BINDING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84896719896     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146632     Document Type: Erratum

References (37)

1. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809. doi:10.1038/362801a0. PubMed: 8479518.
2. Duan C, Bauchat JR, Hsieh T (2000) Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. Circ Res 86: 15-23. doi: 10.1161/01.RES.86.1.15. PubMed: 10625300.
3. Stabile E, Zhou YF, Saji M, Castagna M, Shou M et al. (2003) Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 93: 1059-1065. doi:10.1161/01.RES.0000105086.31909.1B. PubMed: 14605018.
4. Boord JB, Fazio S, Linton MF (2002) Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13: 141-147. doi:10.1097/00041433-200204000-00005. PubMed: 11891416.
5. Fisher RM, Eriksson P, Hoffstedt J, Hotamisligil GS, Thörne A et al. (2001) Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 44: 1268-1273. doi:10.1007/s001250100643. PubMed: 11692175.
6. Fisher RM, Thörne A, Hamsten A, Arner P (2002) Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals. Mol Cell Biochem 239: 95-100. doi:10.1023/A:1020532823751. PubMed: 12479574.
7. Kralisch S, Fasshauer M (2013) Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia, 56: 10-21. PubMed: 23052058.
8. Xu A, Wang Y, Xu JY, Stejskal D, Tam S et al. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52: 405-413. doi:10.1373/clinchem.2005.062463. PubMed: 16423904.
9. Cabré A, Lázaro I, Cofán M, Jarauta E, Plana N et al. (2010) FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res 51: 1173-1178. doi:10.1194/jlr.M900066. PubMed: 20388924.
10. Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F et al. (2007) Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 195: e150-e158. doi:10.1016/j.atherosclerosis.2007.04.045. PubMed: 17553506.
11. Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F et al. (2008) Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin Chem 54: 181-187. PubMed: 18024526.
12. Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F et al. (2008) Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res 49: 1746-1751. doi:10.1194/jlr.M800102-JLR200. PubMed: 18421072.
13. Coll B, Cabre A, Alonso-Villaverde C, Lazaro I, Aragonés G et al. (2008) The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 199: 147-153. doi:10.1016/j.atherosclerosis. 2007.09.032. PubMed: 17983623.
14. Stejskal D, Karpisek M (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 36: 621-625. doi:10.1111/j.1365-2362.2006.01696.x. PubMed: 16919044.
15. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM et al. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115: 1537-1543. doi:10.1161/CIRCULATIONAHA.106.647503. PubMed: 17389279.
16. Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH et al. (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 27: 1796-1802. doi:10.1161/ATVBAHA.107.146274. PubMed: 17510463.
17. von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D et al. (2012) Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 32: 2327-2335. doi:10.1161/ATVBAHA.112.248609. PubMed: 22679309.
18. Doi M, Miyoshi T, Hirohata S, Nakamura K, Usui S et al. (2011) Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol 10: 44. doi:10.1186/1475-2840-10-44. PubMed: 21600061.
19. Agardh HE, Folkersen L, Ekstrand J, Marcus D, Swedenborg J et al. (2011) Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 269: 200-210. doi:10.1111/j.1365-2796.2010.02304.x. PubMed: 21073559.
20. Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M et al. (2011) Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLOS ONE 6: e28785. doi:10.1371/journal. pone.0028785. PubMed: 22174896.
21. Lee K, Santibanez-Koref M, Polvikoski T, Birchall D, Mendelow AD et al. (2013) Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture. Atherosclerosis 226: 74-81. doi:10.1016/j.atherosclerosis.2012.09.037. PubMed: 23122912.
22. Peeters W, de Kleijn DP, Vink A, van de Weg S, Schoneveld AH et al. (2011) Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J 32: 1758-1768. doi:10.1093/eurheartj/ ehq387. PubMed: 21059735.
23. Zimmerman AW, Veerkamp JH (2002) New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 59: 1096-1116. doi:10.1007/s00018-002-8490-y. PubMed: 12222958.
24. Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M et al. (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23: 3865-3873. doi:10.1096/fj.09-134882. PubMed: 19625659.
25. Fischer H, Gustafsson T, Sundberg CJ, Norrbom J, Ekman M et al. (2006) Fatty acid binding protein 4 in human skeletal muscle. Biochem Biophys Res Commun 346: 125-130. doi:10.1016/j.bbrc.2006.05.083. PubMed: 16750515.
26. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U et al. (2009) Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105: 326-334. doi:10.1161/CIRCRESAHA.109.200501. PubMed: 19608978.
27. Aragonès G, Ferré R, Girona J, Plana N, Merino J et al. (2012) Small artery dilation and endothelial markers in cardiovascular risk patients. Eur J Clin Invest 42: 34-41. doi:10.1111/j.1365-2362.2011.02553.x. PubMed: 21631467.
28. Aragonès G, Ferré R, Lázaro I, Cabré A, Plana N et al. (2010) Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis 213: 329-331. doi:10.1016/j.atherosclerosis.2010.07.026. PubMed: 20723896.
29. Aragonès G, Saavedra P, Heras M, Cabré A, Girona J et al. (2012) Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 11: 72. doi:10.1186/1475-2840-11-72. PubMed: 22709426.
30. Lee MY, Li H, Xiao Y, Zhou Z, Xu A et al. (2011) Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. Br J Pharmacol 162: 1564-1576. doi:10.1111/j.1476-5381.2010.01158.x. PubMed: 21175571.
31. Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333. doi:10.1038/nnano.2007.164. PubMed: 17406593.
32. Dzau VJ, Braun-Dullaeus RC, Sedding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8: 1249-1256. doi:10.1038/nm1102-1249. PubMed: 12411952.
33. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959-965. doi:10.1038/nature05844. PubMed: 17554340.
34. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S et al. (2002) Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 22: 1686-1691. doi:10.1161/01.ATV.0000033090.81345.E6. PubMed: 12377750.
35. Lu L, Wang YN, Sun WH, Liu ZH, Zhang Q et al. (2013) Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte Fatty Acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells. Arterioscler Thromb Vasc Biol 33: 572-580. doi:10.1161/ATVBAHA.112.301016. PubMed: 23372061.
36. Elmasri H, Ghelfi E, Yu CW, Traphagen S, Cernadas M et al. (2012) Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 15: 457-468. doi:10.1007/s10456- 012-9274-0. PubMed: 22562362.
37. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9: 726-735. PubMed: 7601337.